Daniela di Giuseppe

About me
Publications
CV
Public outreach and news

About me

-------- ------------------------------------------------------------------
I am a statistician with a doctoral degree in epidemiology from Karolinska
Institutet. Since 2023 I am Docent in Epidemiology. As part of Johan
Askling's research group on chronic inflammatory disease epidemiology,
my research focuses on safety and effectiveness of treatments for chronic
inflammatory diseases, including rheumatoid arthritis(RA), psoriatic
arthritis(PsA) and spondyloarthritis(SpA). Morevoer, I have a deep interest
in the role of environmental risk factor, and in particular diet, on risk and
prognosis of rheumatoid arthritis.
2014, PhD in Medical Science, Karolinska Institutet
2008, MSc in Statistics, University of Milano–Bicocca, Italy
2006, BSc in Statistics, University of Milano–Bicocca, Italy

Research

-------- ------------------------------------------------------------------
I am involved in several national and international collaborations with the
aim of investigate different aspect of rheumatic disease and its treatment:
* ARTIS (Anti-Rheumatic Treatment in Sweden): a national surveillance
program for investigation of safety and effectiveness of new
anti-rheumatic drugs
* Nordforsk collaboration: using data from the 5 Nordic rheumatology
quality register linked to the national register on health, we can analyze
safety and effectiveness of treatments in RA, PsA and SpA
* EuroSpA collaboration: data from 17 national rheumatogy register are
collected to analyze several aspect of treatment for PsA and SpA. I am
part of the EuroSpA scientific committee
* EIRA: using data from the largest case-control study on RA, I have
analyzed the effect of diet on risk and prognosis of RA
-------- ------------------------------------------------------------------

Teaching

Systematic Reviews and Meta-analyses (PhD Course nr. 2790), organizer and
lecturer
Advanced course in SAS programming for Health Care Data, teaching assistant

Articles

Article: JOURNAL OF RHEUMATOLOGY. 2024;:jrheum.2024-jrheum.0376
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden.
Exarchou S; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedrén S; Lindström U; Turesson C; Jacobsson LTH; Askling J; Wallman JK
Article: JOURNAL OF RHEUMATOLOGY. 2024;:jrheum.2024-jrheum.0252
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries.
Provan SA; Ljung L; Kristianslund EK; Michelsen B; Uhlig T; Jonmundsson T; Sexton J; Gudbjornsson B; Di Giuseppe D; Hetland ML; Reynisdottir GB; Glintborg B; Relas H; Aaltonen K; Kvien TK; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2024
Effectiveness of janus kinase inhibitors compared with biologic disease modifying anti-rheumatic drugs on pain reduction in rheumatoid arthritis: Results from a nationwide Swedish cohort study.
Eberhard A; Di Giuseppe D; Askling J; Bergman S; Bower H; Chatzidionysiou K; Forsblad-d'Elia H; Kastbom A; Olofsson T; Frisell T; Turesson C
Article: RMD OPEN. 2024;10(3):e004166
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
Christiansen SN; Horskjær Rasmussen S; Ostergaard M; Pons M; Michelsen B; Pavelka K; Codreanu C; Ciurea A; Glintborg B; Santos MJ; Sari I; Rotar Z; Gudbjornsson B; Macfarlane GJ; Relas H; Iannone F; Laas K; Wallman JK; van de Sande M; Provan SA; Castrejon I; Zavada J; Mogosan C; Nissen MJ; Loft AG; Barcelos A; Erez Y; Pirkmajer KP; Grondal G; Jones GT; Hokkanen A-M; Chimenti MS; Vorobjov S; Di Giuseppe D; Kvien TK; Otero-Varela L; van der Horst-Bruinsma I; Hetland ML; Ørnbjerg LM
Article: RHEUMATOLOGY. 2024;63(7):1882-1892
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Linde L; Ornbjerg LM; Heegaard Brahe C; Wallman JK; Di Giuseppe D; Zavada J; Castrejon I; Diaz-Gonzalez F; Rotar Z; Tomsic M; Glintborg B; Gudbjornsson B; Geirsson AJ; Michelsen B; Kristianslund EK; Santos MJ; Barcelos A; Nordstrom D; Eklund KK; Ciurea A; Nissen M; Akar S; Hejl Hyldstrup L; Krogh NS; Hetland ML; Ostergaard M
Article: JOURNAL OF RHEUMATOLOGY. 2024;51(7):673-677
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
Georgiadis S; Ornbjerg LM; Michelsen B; Kvien TK; Di Giuseppe D; Wallman JK; Zavada J; Provan SA; Kristianslund EK; Rodrigues AM; Santos MJ; Rotar Z; Pirkmajer KP; Nordstrom D; Macfarlane GJ; Jones GT; van der Horst-Bruinsma I; Hellamand P; Ostergaard M; Hetland ML
Article: ARTHRITIS CARE & RESEARCH. 2024
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries
Linde L; Georgiadis S; Ornbjerg LM; Rasmussen SH; Michelsen B; Askling J; Di Giuseppe D; Wallman JK; Zavada J; Pavelka K; Bernardes M; Matos CO; Glintborg B; Loft AG; Nordstrom D; Kuusalo L; Moller B; Nissen MJ; Codreanu C; Mogosan C; Gudbjornsson B; Love TJ; Akleylek C; Iannone F; Kvien TK; Rotar Z; Castrejon I; Macfarlane GJ; Hetland ML; Ostergaard M
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;65:152388
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Christiansen SN; Horskjær Rasmussen S; Pons M; Michelsen B; Glintborg B; Gudbjornsson B; Grondal G; Vencovsky J; Loft AG; Rotar Z; Pirkmajer KP; Nissen MJ; Baranová J; Macfarlane GJ; Jones GT; Iannone F; Caporali R; Laas K; Vorobjov S; Giuseppe DD; Olofsson T; Provan SA; Fagerli KM; Castrejon I; Otero-Varela L; van de Sande M; van der Horst-Bruinsma I; Nordström D; Kuusalo L; Bernardes M; Hetland ML; Østergaard M; Midtbøll Ørnbjerg L
Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(4):446-456
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study
Exarchou S; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedren S; Lindstroem U; Turesson C; Jacobsson LTH; Askling J; Wallman JK
Article: RHEUMATOLOGY. 2024;63(3):751-764
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
Linde L; Ornbjerg LM; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Gudbjornsson B; Love TJ; Nordstrom DC; Yli-Kerttula T; Nekvindova L; Vencovsky J; Iannone F; Cauli A; Loft AG; Glintborg B; Laas K; Rotar Z; Tomsic M; Macfarlane GJ; Moller B; van de Sande M; Codreanu C; Nissen MJ; Birlik M; Erten S; Santos MJ; Vieira-Sousa E; Hetland ML; Ostergaard M
Article: ARTHRITIS CARE & RESEARCH. 2024;76(2):274-287
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry
Yazdany J; Ware A; Wallace ZS; Bhana S; Grainger R; Hachulla E; Richez C; Cacoub P; Hausmann JS; Liew JW; Sirotich E; Jacobsohn L; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Lawson-Tovey S; Kearsley-Fleet L; Schaefer M; Ribeiro SLE; Al-Emadi S; Hasseli R; Mueller-Ladner U; Specker C; Schulze-Koops H; Bernardes M; Fraga VM; Rodrigues AM; Sparks JA; Ljung L; Di Giuseppe D; Tidblad L; Wise L; Duarte-Garcia A; Ugarte-Gil MF; Colunga-Pedraza IJ; Martinez-Martinez MU; Alpizar-Rodriguez D; Xavier RM; Isnardi CA; Pera M; Pons-Estel G; Izadi Z; Gianfrancesco MA; Carrara G; Scire CA; Zanetti A; Machado PM
Article: RMD OPEN. 2023;9(4):e003648
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Lindstrom U; Turesson C; Chatzidionysiou K; Lindqvist E; Knight A; Forsblad-d'Elia H; Askling J
Article: RMD OPEN. 2023;9(4):e003630
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2023;25(1):205
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration
Linde L; Ornbjerg LM; Rasmussen SH; Love TJ; Loft AG; Zavada J; Vencovsky J; Laas K; Nordstrom D; Sokka-Isler T; Gudbjornsson B; Grondal G; Iannone F; Ramonda R; Hellamand P; Kristianslund EK; Kvien TK; Rodrigues AM; Santos MJ; Codreanu C; Rotar Z; Tomsic M; Castrejon I; Diaz-Gonzales F; Di Giuseppe D; Ljung L; Nissen MJ; Ciurea A; Macfarlane GJ; Heddle M; Glintborg B; Ostergaard M; Hetland ML
Article: LANCET REGIONAL HEALTH-EUROPE. 2023;33:100706
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe.
Michelsen B; Østergaard M; Nissen MJ; Ciurea A; Möller B; Ørnbjerg LM; Zavada J; Glintborg B; MacDonald A; Laas K; Nordström D; Gudbjornsson B; Iannone F; Hellmand P; Kvien TK; Rodrigues AM; Codreanu C; Rotar Z; Castrejón Fernández I; Wallman JK; Vencovsky J; Loft AG; Heddle M; Vorobjov S; Hokkanen A-M; Gröndal G; Sebastiani M; van de Sande M; Kristianslund EK; Santos MJ; Mogosan C; Tomsic M; Díaz-González F; Di Giuseppe D; Hetland ML
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(4):374-384
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register
Wallman JK; Alenius G-M; Klingberg E; Sigurdardottir V; Wedren S; Exarchou S; Lindstrom U; Di Giuseppe D; Askling J; Jacobsson LTH
Article: JOURNAL OF RHEUMATOLOGY. 2023;50(6):781-788
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017
Exarchou S; Wallman JK; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedren S; Lindstrom U; Turesson C; Jacobsson LTH; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(6):820-828
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries
Glintborg B; Di Giuseppe D; Wallman JK; Nordstrom DC; Gudbjornsson B; Hetland ML; Askling J; Grondal G; Sokka T; Provan SA; Michelsen B; Kristianslund EK; Dreyer L; Love TJ; Lindstrom U
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(5):601-610
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
Frisell T; Bower H; Morin M; Baecklund E; Di Giuseppe D; Delcoigne B; Feltelius N; Forsblad-d'Elia H; Lindqvist E; Lindstroem U; Askling J
Article: RMD OPEN. 2023;9(2):e002883
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
Lindstrom U; di Giuseppe D; Exarchou S; Alenius G-M; Olofsson T; Klingberg E; Jacobsson L; Askling J; Wallman JK
Article: RHEUMATOLOGY. 2023;62(2):647-658
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries
Glintborg B; Di Giuseppe D; Wallman JK; Provan SA; Nordstrom D; Hokkanen A-M; Osterlund J; Kristianslund E; Kvien TK; Gudbjornsson B; Hetland ML; Michelsen B; Jacobsson L; Askling J; Lindstrom U
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(2):189-197
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis
Molander V; Bower H; Frisell T; Delcoigne B; Di Giuseppe D; Askling J
Article: RHEUMATOLOGY. 2022;61(12):4741-4751
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
Nissen M; Delcoigne B; Di Giuseppe D; Jacobsson L; Hetland ML; Ciurea A; Nekvindova L; Iannone F; Akkoc N; Sokka-Isler T; Fagerli KM; Santos MJ; Codreanu C; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Van der Horst-Bruinsma I; Loft AG; Moeller B; Mann H; Conti F; Cetin GY; Relas H; Michelsen B; Ribeiro PA; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson AJ; Askling J; Glintborg B; Lindstroem U
Article: RHEUMATOLOGY. 2022;61(11):4286-4296
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration
Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornson B; Hetland ML; Michelsen B; Nordstrom D; Relas H; Askling J
Article: RMD OPEN. 2022;8(2):e002465
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking
Chatzidionysiou K; di Giuseppe D; Soderling J; Catrina A; Askling J
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022;56:152081
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration
Ornbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Pavelka K; Zavada J; Nissen MJ; Jones GT; Relas H; Pirila L; Tomsic M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; Horst-Bruinsma IVS; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Ostergaard M; Hetland ML
Article: RHEUMATOLOGY. 2022;61(9):3799-3807
European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response
Christiansen SN; Ornbjerg LM; Rasmussen SH; Loft AG; Askling J; Iannone F; Zavada J; Michelsen B; Nissen M; Onen F; Santos MJ; Pombo-Suarez M; Relas H; Macfarlane GJ; Tomsic M; Codreanu C; Gudbjornsson B; Van der Horst-Bruinsma I; Di Giuseppe D; Glintborg B; Gremese E; Pavelka K; Kristianslund EK; Ciurea A; Akkoc N; Barcelos A; Sanchez-Piedra C; Peltomaa R; Jones GT; Rotar Z; Ionescu R; Grondal G; Van de Sande MGH; Laas K; Ostergaard M; Hetland ML
Article: RHEUMATOLOGY. 2022;61(9):3647-3656
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries
Di Giuseppe D; Lindstrom U; Aaltonen K; Relas H; Provan S; Gudbjornsson B; Hetland ML; Askling J; Kauppi M; Geirsson AJ; Chatzidionysiou K; Jorgensen TS; Dreyer L; Michelsen B; Jacobsson L; Glintborg B
Article: RHEUMATOLOGY. 2022;61(9):3596-3605
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden
Di Giuseppe D; Lindstrom U; Bower H; Delcoigne B; Frisell T; Chatzidionysiou K; Sjowall C; Lindqvist E; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):203
Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA study
Hedenstierna L; Hedstrom AK; Klareskog L; Di Giuseppe D; Alfredsson L; Askling J; Ernestam S; Saevarsdottir S; Ljung L
Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):178
Investigation of the association between coffee and risk of RA-results from the Swedish EIRA study
Westerlind H; Dukuzimana J; Lu X; Alfredsson L; Klareskog L; Di Giuseppe D
Article: ARTHRITIS CARE & RESEARCH. 2022;74(7):1205-1218
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
Michelsen B; Georgiadis S; Di Giuseppe D; Loft AG; Nissen MJ; Iannone F; Pombo-Suarez M; Mann H; Rotar Z; Eklund KK; Kvien TK; Santos MJ; Gudbjornsson B; Codreanu C; Yilmaz S; Wallman JK; Brahe CH; Moeller B; Favalli EG; Sanchez-Piedra C; Nekvindova L; Tomsic M; Trokovic N; Kristianslund EK; Santos H; Love TJ; Ionescu R; Pehlivan Y; Jones GT; Van der Horst-Bruinsma I; Ornbjerg LM; Ostergaard M; Hetland ML
Article: ARTHRITIS CARE & RESEARCH. 2022;74(5):748-758
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
Glintborg B; Lindstrom U; Di Giuseppe D; Provan SA; Gudbjornsson B; Hetland ML; Michelsen B; Wallman JK; Aaltonen K; Hokkanen A-M; Nordstrom D; Jorgensen TS; Hansen RL; Geirsson AJ; Gron KL; Krogh NS; Askling J; Kristensen LE; Jacobsson LTH
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(3):433-439
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?
Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Askling J
Article: HEART. 2022;108(6):467-473
Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden
Rossides M; Kullberg S; Grunewald J; Eklund A; Di Giuseppe D; Askling J; Arkema EV
Article: RMD OPEN. 2021;7(3):e001987
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
Article: RESPIRATORY MEDICINE. 2021;188:106624
Risk of acute myocardial infarction in sarcoidosis: A population-based cohort study from Sweden
Rossides M; Kullberg S; Grunewald J; Eklund A; Di Giuseppe D; Askling J; Arkema EV
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1445-1452
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?
Lindstrom U; Bengtsson K; Olofsson T; Di Giuseppe D; Glintborg B; Forsblad-d'Elia H; Jacobsson LTH; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1410-1418
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Lindstrom U; Di Giuseppe D; Delcoigne B; Glintborg B; Moller B; Ciurea A; Pombo-Suarez M; Sanchez-Piedra C; Eklund K; Relas H; Gudbjornsson B; Love TJ; Jones GT; Codreanu C; Ionescu R; Nekvindova L; Zavada J; Atas N; Yolbas S; Fagerli KM; Michelsen B; Rotar Z; Tomsic M; Iannone F; Santos MJ; Avila-Ribeiro P; Ornbjerg LM; Ostergaard M; Jacobsson LTH; Askling J; Nissen MJ
Article: JOURNAL OF RHEUMATOLOGY. 2021;48(10):1512-1518
Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis
Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Peltomaa R; Aaltonen K; Trokovic N; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Grondal G; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson LTH; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2021;23(1):209
Is tea consumption associated with reduction of risk of rheumatoid arthritis? A Swedish case-control study
Westerlind H; Palmqvist I; Saevarsdottir S; Alfredsson L; Klareskog L; Di Giuseppe D
Article: RHEUMATOLOGY. 2021;60(8):3635-3645
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis
Lindstrom U; Glintborg B; Di Giuseppe D; Jorgensen TS; Gudbjornsson B; Gron KL; Provan SA; Michelsen B; Hetland ML; Wallman JK; Nordstrom D; Trokovic N; Love TJ; Krogh NS; Askling J; Jacobsson LTH; Kristensen LE
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(8):1086-1093
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
Article: RESPIROLOGY. 2021;26(5):452-460
Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data
Rossides M; Kullberg S; Di Giuseppe D; Eklund A; Grunewald J; Askling J; Arkema EV
Article: RHEUMATOLOGY. 2021;60(2):809-819
Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype
Hellgren K; Di Giuseppe D; Smedby KE; Sundstrom C; Askling J; Baecklund E
Article: RHEUMATOLOGY. 2021;60(1):140-146
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study
Hansen RL; Jorgensen TS; Dreyer L; Hetland ML; Glintborg B; Askling J; Di Giuseppe D; Jacobsson LTH; Wallman JK; Nordstrom D; Aaltonen K; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Love TJ; Kristensen LE
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2020;35(11):1087-1097
Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study
Rossides M; Kullberg S; Askling J; Eklund A; Grunewald J; Di Giuseppe D; Arkema EV
Article: EUROPEAN RESPIRATORY JOURNAL. 2020;56(3):2000767
Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study
Rossides M; Kullberg S; Eklund A; Di Giuseppe D; Grunewald J; Askling J; Arkema EV
Article: NUTRIENTS. 2019;11(11):E2825-2825
Consumption of Meat and Dairy Products Is Not Associated with the Risk for Rheumatoid Arthritis among Women: A Population-Based Cohort Study
Sundstrom B; Ljung L; Di Giuseppe D
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(11):1536-1544
Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Ornbjerg LM; Brahe CH; Askling J; Ciurea A; Mann H; Onen F; Kristianslund EK; Nordstrom D; Santos MJ; Codreanu C; Gomez-Reino J; Rotar Z; Gudbjornsson B; Di Giuseppe D; Nissen MJ; Pavelka K; Birlik M; Kvien T; Eklund KK; Barcelos A; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson AJ; Loft AG; van der Horst-Bruinsma I; Jones G; Iannone F; Hyldstrup L; Krogh NS; Hetland ML; Ostergaard M
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(4):326-330
Comparison of agreement between internet-based registration of patient-reported outcomes and clinic-based paper forms within the Swedish Rheumatology Quality Register
Hofstedt O; Di Giuseppe D; Alenius G-M; Stattin N; Forsblad-D'Elia H; Ljung L
Article: RHEUMATOLOGY. 2019;58(8):1367-1377
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register
Frisell T; Dehlin M; Di Giuseppe D; Feltelius N; Turesson C; Askling J; Ernestam S; Klareskog L; Nisell R; Baecklund E; Kastbom A; Jacobsson L; Lindqvist E; d'Elia HF; Rantapaa-Dahlqvist S
Article: RMD OPEN. 2019;5(2):e001079
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naive patients with spondyloarthritis
Lindstrom U; Glintborg B; Di Giuseppe D; Nordstrom D; Provan SA; Gudbjornsson B; Askling J; Hetland ML; Aaltonen K; Krogh NS; Geirsson AJ; Jacobsson LTH
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(6):465-474
Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries
Glintborg B; Lindstrom U; Aaltonen K; Kristianslund EK; Gudbjornsson B; Chatzidionysiou K; Askling J; Nordstrom D; Hetland ML; Di Giuseppe D; Dreyer L; Kristensen LE; Jorgensen TS; Eklund K; Grondal G; Ernestam S; Joensuu J; Tormanen MRK; Skydsgaard H; Hagfors J; Kvien TK; Lie E; Fagerli K; Geirsson AJ; Jonsson H; Provan SA; Krogh NS; Jacobsson LTH
Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):175
Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study
Johansson K; Askling J; Alfredsson L; Di Giuseppe D
Article: EUROPEAN RESPIRATORY JOURNAL. 2018;52(2):1800385
Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study
Rossides M; Grunewald J; Eklund A; Kullberg S; Di Giuseppe D; Askling J; Arkema EV
Article: INTERNATIONAL JOURNAL OF RHEUMATOLOGY. 2018;2018:9152480-7
Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort
Lourdudoss C; Arnaud L; Wolk A; van Vollenhoven RF; Di Giuseppe D
Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2018;18(5):499-504
Uptake of rheumatology biosimilars in the absence of forced switching
Di Giuseppe D; Frisell T; Ernestam S; Forsblad-D'Elia H; Lindqvist E; Lindstrom U; Sjowall C; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(5):650-657
Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics
Frisell T; Baecklund E; Bengtsson K; Di Giuseppe D; Forsblad-d'Elia H; Askling J
Article: ARTHRITIS CARE & RESEARCH. 2018;70(2):205-212
Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis Patients
Lourdudoss C; Di Giuseppe D; Wolk A; Westerlind H; Klareskog L; Alfredsson L; van Vollenhoven RF; Lampa J
Article: EUROPEAN JOURNAL OF NUTRITION. 2017;56(2):843-852
Fish consumption and frying of fish in relation to type 2 diabetes incidence: a prospective cohort study of Swedish men
Wallin A; Di Giuseppe D; Orsini N; Akesson A; Forouhi NG; Wolk A
Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):40
Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study
Di Giuseppe D; Bottai M; Askling J; Wolk A
Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(11):1949-1953
Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women
Di Giuseppe D; Wallin A; Bottai M; Askling J; Wolk A
Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(5):446
Fish consumption and risk of rheumatoid arthritis: a dose-response meta-analysis
Di Giuseppe D; Crippa A; Orsini N; Wolk A
Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(2):R61
Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis
Di Giuseppe D; Discacciati A; Orsini N; Wolk A
Article: EUROPEAN JOURNAL OF NUTRITION. 2014;53(2):549-555
Validity of food frequency questionnaire-based estimates of long-term long-chain n-3 polyunsaturated fatty acid intake
Wallin A; Di Giuseppe D; Burgaz A; Hakansson N; Cederholm T; Michaelsson K; Wolk A
Article: ARTHRITIS RESEARCH & THERAPY. 2013;15(2):R56
Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women
Di Giuseppe D; Orsini N; Alfredsson L; Askling J; Wolk A
Article: BMJ-BRITISH MEDICAL JOURNAL. 2012;345:e4230
Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study
Di Giuseppe D; Alfredsson L; Bottai M; Askling J; Wolk A
Article: DIABETES CARE. 2012;35(4):918-929
Fish Consumption, Dietary Long-Chain n-3 Fatty Acids, and Risk of Type 2 Diabetes Systematic review and meta-analysis of prospective studies
Wallin A; Di Giuseppe D; Orsini N; Patel PS; Forouhi NG; Wolk A
Show more

All other publications

Corrigendum: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;58:152141
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration (vol 56, 152081, 20222)
Ornbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Pavelka K; Zavada J; Nissen MJ; Jones GT; Relas H; Pirila L; Tomsic M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; van der Horst-Bruinsma I; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Ostergaard M; Hetland ML
Corrigendum: RHEUMATOLOGY. 2022;61(12):4998
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration (vol 9, keac081, 2022)
Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornsson B; Hetland ML; Michelsen B; Nordstrom D; Relas H; Askling J
Letter: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2020;49(2):171-172
Comparison of agreement between internet-based registration of patient-reported outcomes and clinical-based paper forms within the Swedish Rheumatology Quality Register: comment on the article by Hofstedt et al Reply
Hofstedt O; Di Giuseppe D; Alenius G-M; Stattin N; Forsblad-D'Elia H; Ljung L
Review: RMD OPEN. 2018;4(1):e000655
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example
Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Aaltonen K; Tormanen MRK; Kristianslund EK; Kvien TK; Provan SA; Guobjornsson B; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson L; Askling J
Thesis / dissertation: 2014
Diet and other environmental factors and the risk of rheumatoid arthritis in a population-based prospective cohort study
Di Giuseppe, Daniela

Employments

Statistician, Department of Medicine, Karolinska Institutet, 2015-

Degrees and Education

Docent, Karolinska Institutet, 2023
Degree Of Doctor Of Philosophy, Institute of Environmental Medicine, Karolinska Institutet, 2014

Supervisor

Marie-Louise Karlsson, The impact of lifestyle changes, and treatment adherence in Early Rheumatoid Arthritis, 2023

About me

Research

Teaching

Articles

All other publications

Employments

Degrees and Education

Supervisor

News from KI

Events from KI